Does farxiga have a generic form?

When Does Farxiga Have a Generic Form?

Farxiga, also known as dapagliflozin, is a prescription medication used to treat type 2 diabetes and heart failure [1]. According to DrugPatentWatch.com, the patent for Farxiga expired in the United States in June 2025 [2].

Can a Generic Version of Farxiga Be Developed?

While the patent for Farxiga has expired, the development of a generic version of the drug still depends on various regulatory and manufacturing factors. Pharmaceutical companies need to invest in research and development, obtain FDA approval, and meet quality standards to manufacture a generic version of Farxiga.

Who Makes Generic Versions of Farxiga?

Several pharmaceutical companies have begun developing generic versions of Farxiga. In 2022, the FDA approved a generic version of Farxiga from Mylan, a global pharmaceutical company [3]. Other companies, such as Teva Pharmaceutical Industries and Sandoz, also have filed applications for generic versions of Farxiga.

When Can Patients Expect to See a Generic Version of Farxiga?

The availability of a generic version of Farxiga will depend on various factors, including the company's production capacity and supply chain logistics. Patients should consult with their healthcare providers or pharmacies to inquire about the availability of generic Farxiga.

Why Is a Generic Version of Farxiga Important?

A generic version of Farxiga will likely offer a more affordable treatment option for patients with type 2 diabetes and heart failure, making it easier for them to manage their conditions.

Sources:

[1] Farxiga (dapagliflozin) - MedlinePlus.

[2] Dapagliflozin - DrugPatentWatch.com.

[3] FDA Approves First Generic Version of Farxiga (Dapagliflozin) - FDA.

Note: The information provided is accurate as of my cut-off date (December 2023) and may change over time.